Publications (165) JUAN CARLOS GOMEZ ESTEBAN publications

filter_list

2025

  1. Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease

    Annals of Clinical and Translational Neurology, Vol. 12, Núm. 4, pp. 768-779

  2. Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study

    Computers in Biology and Medicine, Vol. 185

  3. Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington’s disease

    Scientific Reports, Vol. 15, Núm. 1

  4. Deep Brain Stimulation for Status Dyskineticus in ADCY5-Related Dyskinesia in a 60-Year-Old Woman

    Movement Disorders Clinical Practice

  5. Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

    PLoS ONE, Vol. 20, Núm. 3 March

  6. Dynamics of retinal changes in early-stage Parkinson's disease

    Acta neuropathologica communications, Vol. 13, Núm. 1, pp. 20

  7. Effect of sex on the progression of non-motor symptoms in Parkinson's disease: A registry-based cohort study

    Neurologia

  8. Erratum: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions (Neuron (2024) 112(17) (2886–2909.e16), (S0896627324004094), (10.1016/j.neuron.2024.06.002))

    Neuron

  9. Evaluating prognostic factors for falls in Parkinson's disease: A sex-based analysis

    Clinical Neurology and Neurosurgery, Vol. 249

  10. Fatigue brain network functional connectivity in Parkinson's disease

    Neuroscience, Vol. 579, pp. 122-128

  11. Small fiber neuropathy in the post-COVID condition and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical significance and diagnostic challenges

    European Journal of Neurology, Vol. 32, Núm. 2

  12. Virtual coach and telerehabilitation for Parkinson´s disease patients: vCare system

    Journal of Public Health (Germany), Vol. 33, Núm. 7, pp. 1583-1596

2024

  1. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Designing Virtual Coaching Solutions: Design and Evaluation of a Digital Health Intervention for Rehabilitation

    Business and Information Systems Engineering, Vol. 66, Núm. 3, pp. 377-400

  3. Implication of nutrition in severity of symptoms and treatments in quality of life in Parkinson’s disease: a systematic review

    Frontiers in Nutrition, Vol. 11

  4. Machine Learning for Prediction of Cognitive Deterioration in Patients with Early Parkinson’s Disease

    Applied Sciences (Switzerland), Vol. 14, Núm. 18

  5. Plasma Neurofilament Light Chain: A Potential Biomarker for Neurological Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Biomedicines, Vol. 12, Núm. 7

  6. Predicting Parkinson’s Disease Progression: Analyzing Prodromal Stages Through Machine Learning

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  7. Prognostic factors for falls in Parkinson’s disease: a systematic review

    Acta Neurologica Belgica, Vol. 124, Núm. 2, pp. 395-406

  8. Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

    Neuron, Vol. 112, Núm. 17, pp. 2886-2909.e16